Matis Louis Insider Trades

Insider Trading History

Track insider trading activity for Matis Louis. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Chief Development Officer
Holding Value $1.31M 96,500 shares
Last Trade
Feb 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.9M 96,500 shares
$247.20
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Chief Development Officer
Holding Value $1.36M 100,000 shares
Last Trade
Feb 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68.5M 100,000 shares
$684.80
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
See Remarks
Holding Value $1.97M 145,000 shares
Last Trade
Feb 23, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.1M 145,000 shares
$159.20
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Svp, Chief Development Officer
Holding Value $136k 10,000 shares
Last Trade
Jun 14, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.04M 7,915 shares
$131.20
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Svp, Chief Development Officer
Holding Value $28.4k 2,085 shares
Last Trade
Jun 13, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$282k 2,085 shares
$135.20
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Svp, Chief Development Officer
Holding Value $6.8M 500,000 shares
Last Trade
Aug 17, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$134M 500,000 shares
$268.80
$13.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up